• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Partners

3 Senior Living Providers Merge to Form Curana Health

by Jasmine Pennic 05/04/2022 Leave a Comment

3 Senior Living Providers Merge to Form Curana Health

What You Should Know: - Three leading organizations that provide healthcare services to senior living communities – Elite Patient Care, Provider Health Services, and AllyAlign Health – have joined forces to form Curana Health. Curana Health’s mission is to improve the health, happiness, and dignity of senior living residents. The Curana Health ACO is a value-based care program for original Medicare beneficiaries. - The combined Curana Health organization spans 26 states and over 1000+
Read More

Arcadia & Datavant Partner to Accelerate Whole-Person Care & Biopharma Research

by Fred Pennic 05/04/2022 Leave a Comment

Arcadia Partners with Datavant to Accelerate Whole-Person Care & Biopharma Research

What You Should Know: - Arcadia and Datavant today announced a partnership to enable de-identified connectivity of Arcadia’s electronic health record data for life sciences research and commercial analytics. - This partnership will unlock fresh insights to accelerate whole-person care and biopharma research, extending Arcadia’s leadership in empowering a data-driven transformation of healthcare. - Datavant will allow clients to connect Arcadia data to other types of Real World Data
Read More

Banner Health Invests In Atlas Healthcare Partners

by Strategic Investments 05/03/2022 Leave a Comment

Banner Health Invests In Atlas Healthcare Partners

What You Should Know: - Atlas Healthcare Partners (Atlas), which specializes in developing and managing ambulatory surgery centers (ASCs) in partnerships with health systems and physicians, announced today that Banner Health has invested into Atlas. - Atlas formed a joint venture partnership with Banner in 2018 to develop and operate a network of ASCs in Arizona, Colorado, and Wyoming. This strategy has resulted in significant growth over the last three years, expanding from eight ASCs to
Read More

Element5 Secures $30M to Expand Automation for Post-Acute Care

by Fred Pennic 05/03/2022 Leave a Comment

Element5 Secures $30M to Expand Automation for Post-Acute Care

What You Should Know: - Element5, the world’s first Automation-as-a-Service solution purpose-built for post-acute care, today announced that it has raised $30 million in a Series B funding round led by Insight Partners.  With the closing of the Series B funding round, Element5 has raised $48.5M in total capital to date.  - This investment will strengthen Element5’s position and enable the company to continue the disruption of the health care industry’s $400B post-acute
Read More

Hello Heart Raises $70M to Expand Heart Health Solutions

by Fred Pennic 05/02/2022 Leave a Comment

Hello Heart Raises $70M to Expand Heart Health Solutions

What You Should Know: - Hello Heart, the only digital therapeutics company focused exclusively on heart disease, announced a $70M Series D funding round led by Stripes to support its rapid growth in the employer market  - The funding round will specifically support the increase in employer market demand for Hello Heart’s technology as a focus on heart health sharpens. The company has experienced massive growth in the employer market, doubling the number of clients in the last three
Read More

Kelonia Therapeutics Emerges with $50M to Deliver Precision Targeted Genetic Medicines

by Fred Pennic 05/02/2022 Leave a Comment

Kelonia Therapeutics Emerges with $50M to Deliver Precision Targeted Genetic Medicines

What You Should Know: - Kelonia Therapeutics, a Boston-based biotech company focused on vivo gene delivery, launched with a $50 million in Series A funding to expand the benefit and reach of genetic medicines. - Despite life-changing responses, existing gene therapies are highly complex, costly, and limited by complicated treatment paradigms, tractable therapeutic applications, and dose-limiting toxicities. By enabling precisely targeted, highly efficient, manufacturable “off-the-shelf” in
Read More

Health Tech VC Firm Flare Capital Partners Closes $350M Fund

by Fred Pennic 04/29/2022 Leave a Comment

Health Tech VC Firm Flare Capital Partners Closes $255M Fund

What You Should Know: - Flare Capital Partners, a Boston-based healthcare technology venture capital firm closes its third fund with $350M, which follows up on its prior two funds raised in July 2019 and the inaugural fund raised in April 2015, respectively. - The most recent fund, establishes Flare Capital Partners as one of the largest, independent, early-stage venture capital firms dedicated to healthcare technology. “When we started the firm in 2014, over $4.5 billion was invested
Read More

NotiSphere Raises $3.6M to Scale Medical Recall Platform

by Fred Pennic 04/28/2022 Leave a Comment

NotiSphere Raises $3.6M to Scale Medical Recall Platform

What You Should Know: - NotiSphere, a healthcare technology startup focused on transforming the medical recall alert process by directly connecting suppliers to recall coordinators at healthcare organizations, today announced a $3.6 million Series Seed round led by Royal Street Ventures, with participation from Okapi Ventures, Stage Venture Partners, Revolution's Rise of the Rest Seed Fund, Coelius Capital, Supernode Ventures and Cedars Sinai Health Ventures. This latest financing brings
Read More

3 Predictions for Post-COVID Clinical Trial Decentralization

by Marc Leighton, VP of Product at Florence Healthcare 04/27/2022 Leave a Comment

3 Predictions for Post-COVID Clinical Trial Decentralization

Prior to COVID, major technological transformation initiatives were already underway at many clinical trial sites, sponsors, and contract research organizations (CROs.) But the move to decentralized trials accelerated dramatically in 2020 and 2021–and it’s not slowing down.  Survey data from WCG Avoca shows that research sites and sponsors expect 89% of clinical trials to qualify as a hybrid, with a mix of decentralized technology and in-person visits.  But what will these
Read More

DiA Imaging Analysis Partners with Intel to Improve Ultrasound Analysis by 40%

by Fred Pennic 04/26/2022 Leave a Comment

DiA Imaging Analysis Partners with Intel to Improve Ultrasound Analysis by 40%

What You Should Know: - DiA Imaging Analysis Ltd, a global provider of AI-powered ultrasound analysis software, has teamed up with Intel to streamline artificial intelligence (AI) solutions used by echocardiography (Echo) labs. - DiA’s AI-based software, LVivo Seamless™, automatically analyzes cardiac ultrasound images using the Intel® Distribution of OpenVINO™ toolkit, to optimize processing time by over 40% percent while maintaining accuracy. Accelerating Processing Times for AI-Based
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 30
  • Go to page 31
  • Go to page 32
  • Go to page 33
  • Go to page 34
  • Interim pages omitted …
  • Go to page 101
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |